Patents by Inventor Inbal Shumacher

Inbal Shumacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124425
    Abstract: The present disclosure encompasses solid state forms of Belumosudil, in embodiments crystalline polymorphs of Belumosudil or salts thereof, processes for preparation thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: December 22, 2023
    Publication date: April 18, 2024
    Inventors: Polina Lapido, Inbal Shumacher, Ofir Shaul
  • Patent number: 11932627
    Abstract: The present disclosure encompasses solid state forms of Belumosudil, in embodiments crystalline polymorphs of Belumosudil or salts thereof, processes for preparation thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: August 22, 2023
    Date of Patent: March 19, 2024
    Assignee: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    Inventors: Polina Lapido, Inbal Shumacher, Ofir Shaul
  • Patent number: 11891380
    Abstract: The present disclosure encompasses solid state forms of Belumosudil, in embodiments crystalline polymorphs of Belumosudil or salts thereof, processes for preparation thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: August 22, 2023
    Date of Patent: February 6, 2024
    Assignee: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    Inventors: Polina Lapido, Inbal Shumacher, Ofir Shaul
  • Publication number: 20230391755
    Abstract: The present disclosure encompasses solid state forms of Belumosudil, in embodiments crystalline polymorphs of Belumosudil or salts thereof, processes for preparation thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: August 22, 2023
    Publication date: December 7, 2023
    Inventors: Polina Lapido, Inbal Shumacher, Ofir Shaul
  • Patent number: 11773083
    Abstract: The present disclosure encompasses solid state forms of Belumosudil, in embodiments crystalline polymorphs of Belumosudil or salts thereof, processes for preparation thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: December 6, 2022
    Date of Patent: October 3, 2023
    Assignee: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    Inventors: Polina Lapido, Inbal Shumacher, Ofir Shaul
  • Publication number: 20230117059
    Abstract: The present disclosure encompasses solid state forms of Belumosudil, in embodiments crystalline polymorphs of Belumosudil or salts thereof, processes for preparation thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: December 6, 2022
    Publication date: April 20, 2023
    Inventors: Polina Lapido, Inbal Shumacher, Ofir Shaul